Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H I Mosberg

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioidsJ J Galligan, H I Mosberg, R Hurst, et al.
European Journal of Pharmacology|June 8, 1989
Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalinJ S Heyman, J L Vaught, H I Mosberg, et al.
International Journal of Peptide and Protein Research|November 1, 1980
Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonistsV J Hruby, H I Mosberg, M E Hadley, et al.
European Journal of Pharmacology|January 17, 1991
Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the delta non-complexed-opioid receptorA Mattia, T Vanderah, H I Mosberg, et al.
International Journal of Peptide and Protein Research|July 1, 1988
Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalinH I Mosberg, R C Haaseth, K Ramalingam, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptorsF Porreca, A E Takemori, M Sultana, et al.
Neuropeptides|February 1, 1985
Studies in vitro with ICI 174,864, [D-Pen2, D-Pen5]-enkephalin (DPDPE) and [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO)L D Hirning, H I Mosberg, R Hurst, et al.
International Journal of Peptide and Protein Research|March 1, 1991
Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptideD L Heyl, J R Omnaas, K Sobczyk-Kojiro, et al.
Molecular Pharmacology|December 1, 1990
Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activityH I Mosberg, D L Heyl, R C Haaseth, et al.
Pharmacology, Biochemistry, and Behavior|July 1, 1986
Centrally-administered opioid selective agonists inhibit drinking in the ratR L Spencer, D Deupree, S Hsiao, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioidsJ J Galligan, H I Mosberg, R Hurst, et al.
European Journal of Pharmacology|June 8, 1989
Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalinJ S Heyman, J L Vaught, H I Mosberg, et al.
International Journal of Peptide and Protein Research|November 1, 1980
Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonistsV J Hruby, H I Mosberg, M E Hadley, et al.
European Journal of Pharmacology|January 17, 1991
Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the delta non-complexed-opioid receptorA Mattia, T Vanderah, H I Mosberg, et al.
International Journal of Peptide and Protein Research|July 1, 1988
Role of steric interactions in the delta opioid receptor selectivity of [D-Pen2, D-Pen5]enkephalinH I Mosberg, R C Haaseth, K Ramalingam, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1992
Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptorsF Porreca, A E Takemori, M Sultana, et al.
Neuropeptides|February 1, 1985
Studies in vitro with ICI 174,864, [D-Pen2, D-Pen5]-enkephalin (DPDPE) and [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAGO)L D Hirning, H I Mosberg, R Hurst, et al.
International Journal of Peptide and Protein Research|March 1, 1991
Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptideD L Heyl, J R Omnaas, K Sobczyk-Kojiro, et al.
Molecular Pharmacology|December 1, 1990
Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activityH I Mosberg, D L Heyl, R C Haaseth, et al.
Pharmacology, Biochemistry, and Behavior|July 1, 1986
Centrally-administered opioid selective agonists inhibit drinking in the ratR L Spencer, D Deupree, S Hsiao, et al.
Pageof 10